BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 12053708)

  • 21. A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.
    Anosova NG; Cole LE; Li L; Zhang J; Brown AM; Mundle S; Zhang J; Ray S; Ma F; Garrone P; Bertraminelli N; Kleanthous H; Anderson SF
    Clin Vaccine Immunol; 2015 Jul; 22(7):711-25. PubMed ID: 25924765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of Clostridium difficile-associated diarrhoea.
    Pothoulakis C
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1041-7. PubMed ID: 8944363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to
    Lewis BB; Carter RA; Ling L; Leiner I; Taur Y; Kamboj M; Dubberke ER; Xavier J; Pamer EG
    mBio; 2017 Aug; 8(4):. PubMed ID: 28790208
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.
    Castagliuolo I; Riegler M; Pasha A; Nikulasson S; Lu B; Gerard C; Gerard NP; Pothoulakis C
    J Clin Invest; 1998 Apr; 101(8):1547-50. PubMed ID: 9541482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
    Borriello SP; Ketley JM; Mitchell TJ; Barclay FE; Welch AR; Price AB; Stephen J
    J Med Microbiol; 1987 Aug; 24(1):53-64. PubMed ID: 3612744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile and antibiotic associated diarrhoea in Sweden.
    Aronsson B; Möllby R; Nord CE
    Scand J Infect Dis Suppl; 1982; 35():53-8. PubMed ID: 6962998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
    Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
    Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on Clostridium difficile and antimicrobial associated diarrhea or colitis].
    Kobayashi T
    Jpn J Antibiot; 1983 Feb; 36(2):464-76. PubMed ID: 6854944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
    Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
    J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Clostridium difficile-associated intestinal disease.
    Rolfe RD
    Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile: its disease and toxins.
    Lyerly DM; Krivan HC; Wilkins TD
    Clin Microbiol Rev; 1988 Jan; 1(1):1-18. PubMed ID: 3144429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.
    Lozniewski A; Rabaud C; Dotto E; Weber M; Mory F
    J Clin Microbiol; 2001 May; 39(5):1996-8. PubMed ID: 11326033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile toxin A in infants.
    Libby JM; Donta ST; Wilkins TD
    J Infect Dis; 1983 Sep; 148(3):606. PubMed ID: 6619580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk.
    Davis MY; Zhang H; Brannan LE; Carman RJ; Boone JH
    Microbiome; 2016 Oct; 4(1):53. PubMed ID: 27717398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prospect for vaccines to prevent Clostridium difficile infection.
    Ghose C; Kelly CP
    Infect Dis Clin North Am; 2015 Mar; 29(1):145-62. PubMed ID: 25677708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections].
    Barbut F; Petit JC
    Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
    Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
    J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model.
    Alcantara C; Stenson WF; Steiner TS; Guerrant RL
    J Infect Dis; 2001 Sep; 184(5):648-52. PubMed ID: 11474431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diarrhea induced by antibiotics].
    Mittermayer H
    Wien Med Wochenschr; 1989 May; 139(9):202-6. PubMed ID: 2662616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.